about
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cellsHealthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients.Intelligent Mechanisms of Macrophage Apoptosis Subversion by MycobacteriumHuman cytomegalovirus-encoded MicroRNAs: A master regulator of latent infection
P50
description
investigador
@es
researcher
@en
name
Ayman A M Alameen
@en
type
label
Ayman A M Alameen
@en
prefLabel
Ayman A M Alameen
@en
P108
P31
P496
0000-0002-8467-9692